Authored by Iain Farrance, PhD, Technical Marketing Associate Introduction Human mesenchymal stromal cells (hMSC) are considered the “workhorse” of Regenerative Medicine (RegenMed). hMSC are a critical starting material in a growing variety of ... More
We’re thrilled to share that we’ve been named a Frederick County Best Places to Work! This award is especially meaningful to us because our company was built with culture in ... More
Authored by Katrina Adlerz, Ph.D., Scientist, Analytics, Product & Process Development & Josephine Lembong, Ph.D., Scientist, Analytics, Product & Process Development The 2019 International Society for Cell and Gene Therapy (ISCT) ... More
Authored by Mayasari Lim, Ph.D., Regional Account Manager, West Coast, RoosterBio Bioprinting overview The field of 3D bioprinting has exploded in recent years largely due to the advances in additive ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Previously, we published a blog post on estimating hMSC ... More
Authored by Joseph Candiello, Ph.D., Technical Application Specialist Human Mesenchymal Stem/Stromal Cells (hMSCs) are a critical starting material in a growing variety of established and emerging applications spanning the Regenerative ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon A. Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Jon Rowley, RoosterBio’s Founder and Chief Product Officer, gave a talk at ... More
Authored by Katrina Adlerz, Ph.D. Scientist, Analytical Development, RoosterBio Inc. RoosterBio attended the International Society for Cell Therapy annual meeting, held May 2-5, 2018 in Montreal, which brought together leaders ... More
Novel cell and cell-based therapies require stringent manufacturing, testing, and oversight to ensure integrity, function, and above all else, patient safety upon administration. Tissue-derived cellular products are considered to be ... More
Contributed by: Timothy R. Olsen, Ph.D. – Sr. Scientist, Process and Product Development at RoosterBio Inc. After the National Institute for Standards and Technology (NIST) identified upcoming challenges in the U.S. ... More